Results of a real-world study that included people with hemophilia from 33 countries show that people with hemophilia B, ...

Immune checkpoint inhibitors, such as Opdivo (nivolumab) and Keytruda (pembrolizumab), have been a huge advance in the ...

Recently reported results from an open-label extension trial show positive safety and efficacy results after 52 weeks of use ...

Alli Oakes, executive director of research at Trilliant Health, shared that upcoding is a “prime example” of healthcare waste ...

FDA-approved as the first and only approved first line treatment for advanced squamous cell carcinoma of the anal canal.

Muscle weakness has the biggest impact on patients’ ability to walk, but other factors matter too, researchers found.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

A new law in Iowa, if signed by the governor, will mandate 100% pass-through of rebates, increased financial transparency, ...